129 related articles for article (PubMed ID: 27749053)
1. Sulfamide as Zinc Binding Motif in Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa).
Halland N; Czech J; Czechtizky W; Evers A; Follmann M; Kohlmann M; Schreuder HA; Kallus C
J Med Chem; 2016 Oct; 59(20):9567-9573. PubMed ID: 27749053
[TBL] [Abstract][Full Text] [Related]
2. Novel Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) from Natural Product Anabaenopeptin.
Halland N; Brönstrup M; Czech J; Czechtizky W; Evers A; Follmann M; Kohlmann M; Schiell M; Kurz M; Schreuder HA; Kallus C
J Med Chem; 2015 Jun; 58(11):4839-44. PubMed ID: 25990761
[TBL] [Abstract][Full Text] [Related]
3. Phosphinanes and Azaphosphinanes as Potent and Selective Inhibitors of Activated Thrombin-Activatable Fibrinolysis Inhibitor (TAFIa).
Schaffner AP; Sansilvestri-Morel P; Despaux N; Ruano E; Persigand T; Rupin A; Mennecier P; Vallez MO; Raimbaud E; Desos P; Gloanec P
J Med Chem; 2021 Apr; 64(7):3897-3910. PubMed ID: 33764059
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for the selective inhibition of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) by a selenium-containing inhibitor with chloro-aminopyridine as a basic group.
Itoh T; Yoshimoto N; Hirano Y; Yamamoto K
Bioorg Med Chem Lett; 2018 Jul; 28(13):2256-2260. PubMed ID: 29859906
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of conformationally restricted inhibitors of active thrombin activatable fibrinolysis inhibitor (TAFIa).
Brink M; Dahlén A; Olsson T; Polla M; Svensson T
Bioorg Med Chem; 2014 Apr; 22(7):2261-8. PubMed ID: 24588961
[TBL] [Abstract][Full Text] [Related]
6. Isolation, Co-Crystallization and Structure-Based Characterization of Anabaenopeptins as Highly Potent Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa).
Schreuder H; Liesum A; Lönze P; Stump H; Hoffmann H; Schiell M; Kurz M; Toti L; Bauer A; Kallus C; Klemke-Jahn C; Czech J; Kramer D; Enke H; Niedermeyer THJ; Morrison V; Kumar V; Brönstrup M
Sci Rep; 2016 Sep; 6():32958. PubMed ID: 27604544
[TBL] [Abstract][Full Text] [Related]
7. Flat SAR of P3-methylsulphonamide based small molecule legumain inhibitors.
Ness KA; Eddie SL; Burton S; Harrison T; Mullan P; Williams R
Bioorg Med Chem Lett; 2016 Jan; 26(2):413-416. PubMed ID: 26653614
[TBL] [Abstract][Full Text] [Related]
8. Discovery of potent & selective inhibitors of activated thrombin-activatable fibrinolysis inhibitor for the treatment of thrombosis.
Bunnage ME; Blagg J; Steele J; Owen DR; Allerton C; McElroy AB; Miller D; Ringer T; Butcher K; Beaumont K; Evans K; Gray AJ; Holland SJ; Feeder N; Moore RS; Brown DG
J Med Chem; 2007 Nov; 50(24):6095-103. PubMed ID: 17990866
[TBL] [Abstract][Full Text] [Related]
9. Discovery of the first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor.
Mori M; Moraca F; Deodato D; Ferraris DM; Selchow P; Sander P; Rizzi M; Botta M
Bioorg Med Chem Lett; 2014 Jun; 24(11):2508-11. PubMed ID: 24767848
[TBL] [Abstract][Full Text] [Related]
10. Rationally designed sulfamides as glutamate carboxypeptidase II inhibitors.
Choy CJ; Fulton MD; Davis AL; Hopkins M; Choi JK; Anderson MO; Berkman CE
Chem Biol Drug Des; 2013 Nov; 82(5):612-9. PubMed ID: 23773397
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for inhibition of carboxypeptidase B by selenium-containing inhibitor: selenium coordinates to zinc in enzyme.
Yoshimoto N; Itoh T; Inaba Y; Ishii H; Yamamoto K
J Med Chem; 2013 Oct; 56(19):7527-35. PubMed ID: 24010887
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures of potent thiol-based inhibitors bound to carboxypeptidase B.
Adler M; Bryant J; Buckman B; Islam I; Larsen B; Finster S; Kent L; May K; Mohan R; Yuan S; Whitlow M
Biochemistry; 2005 Jul; 44(26):9339-47. PubMed ID: 15982000
[TBL] [Abstract][Full Text] [Related]
13. Oxygenated analogues of UK-396082 as inhibitors of activated thrombin activatable fibrinolysis inhibitor.
Owen DR; Bull DJ; Bunnage ME; Glossop MS; Maguire RJ; Strang RS
Bioorg Med Chem Lett; 2010 Jan; 20(1):92-6. PubMed ID: 19954973
[TBL] [Abstract][Full Text] [Related]
14. 3-Mercaptopropionic acids as efficacious inhibitors of activated thrombin activatable fibrinolysis inhibitor (TAFIa).
Islam I; Bryant J; May K; Mohan R; Yuan S; Kent L; Morser J; Zhao L; Vergona R; White K; Adler M; Whitlow M; Buckman BO
Bioorg Med Chem Lett; 2007 Mar; 17(5):1349-54. PubMed ID: 17189688
[TBL] [Abstract][Full Text] [Related]
15. Stabilization versus inhibition of TAFIa by competitive inhibitors in vitro.
Walker JB; Hughes B; James I; Haddock P; Kluft C; Bajzar L
J Biol Chem; 2003 Mar; 278(11):8913-21. PubMed ID: 12643276
[TBL] [Abstract][Full Text] [Related]
16. A novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) - part I: pharmacological characterization.
Wang YX; Zhao L; Nagashima M; Vincelette J; Sukovich D; Li W; Subramanyam B; Yuan S; Emayan K; Islam I; Hrvatin P; Bryant J; Light DR; Vergona R; Morser J; Buckman BO
Thromb Haemost; 2007 Jan; 97(1):45-53. PubMed ID: 17200770
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of imidazole acetic acid inhibitors of activated thrombin-activatable fibrinolysis inhibitor as novel antithrombotics.
Barrow JC; Nantermet PG; Stauffer SR; Ngo PL; Steinbeiser MA; Mao SS; Carroll SS; Bailey C; Colussi D; Bosserman M; Burlein C; Cook JJ; Sitko G; Tiller PR; Miller-Stein CM; Rose M; McMasters DR; Vacca JP; Selnick HG
J Med Chem; 2003 Dec; 46(25):5294-7. PubMed ID: 14640538
[TBL] [Abstract][Full Text] [Related]
18. Identification of covalent active site inhibitors of dengue virus protease.
Koh-Stenta X; Joy J; Wang SF; Kwek PZ; Wee JL; Wan KF; Gayen S; Chen AS; Kang C; Lee MA; Poulsen A; Vasudevan SG; Hill J; Nacro K
Drug Des Devel Ther; 2015; 9():6389-99. PubMed ID: 26677315
[TBL] [Abstract][Full Text] [Related]
19. TAFIa inhibitors in the treatment of thrombosis.
Bunnage ME; Owen DR
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):480-6. PubMed ID: 18600565
[TBL] [Abstract][Full Text] [Related]
20. Design and characterization of a selenium-containing inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa), a zinc-containing metalloprotease.
Yoshimoto N; Sasaki T; Sugimoto K; Ishii H; Yamamoto K
J Med Chem; 2012 Sep; 55(17):7696-705. PubMed ID: 22891675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
